Research and Markets has announced the addition of the "Menopause Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Menopause Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Menopause market. It covers emerging therapies for Menopause in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Menopause pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Menopause pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Menopause pipeline products by the company.

Short-term Launch Highlights:

Find out which Menopause pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Menopause phase 3 clinical trial pipeline products
  • Menopause phase 2 clinical trial pipeline products
  • Menopause phase 1 clinical trial pipeline products
  • Menopause preclinical research pipeline products
  • Menopause discovery stage pipeline products
  • Menopause pipeline products short-term launch highlights

Key Topics Covered:

1. Menopause Pipeline by Stages

2. Menopause Pipeline by Drug Class

3. Menopause Pipeline by Company

4. Menopause Phase 3 Clinical Trial Insights

5. Menopause Phase 2 Clinical Trial Insights

6. Menopause Phase 1 Clinical Trial Insights

7. Menopause Preclinical Research Insights

8. Menopause Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/svsd3k/menopause